The Union Government has issued Operational guidelines for Production Linked Incentive Scheme of Pharmaceuticals. Department of Pharmaceuticals has notified the ‘Production Linked Incentive (PLI) Scheme for Pharmaceuticals’ in March this year with a view to enhance India’s manufacturing capabilities by increasing investment and production in the sector. The approved outlay of the scheme is 15 thousand crore rupees. The scheme envisages to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains. Ministry of Chemicals and Fertilizers in a statement said that the operational guidelines for the scheme was prepared based on a series of consultations with pharmaceutical industry and stakeholders in the Government.
The scheme is now open to applications from the industry and are invited in three groups based on the Global Manufacturing Revenue of Financial Year 2019-20 of the applicants. All the applications will be submitted through an online portal maintained by SIDBI, the Project Management Agency for the scheme.
The application window is for 60 days starting from 2nd of June to 31st of July. The eligible products have been categorized into three categories. The products covered under the scheme are formulations, biopharmaceuticals, active pharmaceutical ingredients, key starting material, drug intermediates and in-vitro diagnostic medical devices.Based on clearly laid out selection criteria given in the guidelines, a maximum of 55 applicants will be selected under the scheme.
The Ministry said, an Empowered Group of Secretaries will undertake periodic reviews of the scheme to ensure its smooth implementation along with the other PLI schemes of the Government of India. A Technical Committee will assist the department in all technical issues which arise during the implementation of the scheme.